FdaApplication
NDA 217417
Identifiers
- fda_app_no: NDA217417
Properties
| Property | Value |
|---|---|
| applicant_name | MUNDIPHARMA GMBH |
| application_type | NDA |
| approval_date | 2023-03-22 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| REZZAYO | REZAFUNGIN ACETATE | EQ 200MG BASE/VIAL | POWDER;INTRAVENOUS |
1 product